Press Enter to search · Esc to close
A 23,000-adult Chinese study suggests high-sensitivity CRP, a routine inflammation marker, tracks who slides into — and out of — metabolic syndrome. For parents juggling everything, it may be a useful early signal.
A new analysis of more than 7,500 older adults suggests very high HDL — long sold as the 'good' cholesterol — may track with lower cognitive scores. Here's what tired parents need to know about their own labs (and their parents' labs).
A new post-hoc analysis tracks inflammatory and immune markers in adults with type 2 diabetes for two years on a carb-restricted, ketogenic plan — and the signal goes well beyond blood sugar.
Endocrinologists are quietly rewriting the rulebook — treating diabetes, fatty liver, and heart disease as one slow-burning inflammatory story. Here's what that means for the rest of us.
A new mouse study reframes the molecule behind your burning legs as a messenger, not a metabolic leftover — and hints at why intense training keeps outperforming easy cardio on the metrics that matter.
GLP-1s deliver durable fat loss and metabolic wins — but a maturing evidence base is also flagging ocular signals and structural changes worth knowing before you pin or pass.
New meta-analyses suggest the metabolic-drug story is moving past the scale — toward measurable inflammation reduction and stacked cardiorenal protection. Here's what that actually changes for a 40-year-old.
A once-daily oral GLP-1, fresh data linking the class to lower lumbar disease risk, and a network meta-analysis hinting at a nuanced colorectal cancer question. Here's what the moderate evidence actually says.
Semaglutide reshaped the conversation around obesity. The next round of data — from skeletal muscle to intracranial pressure to oral small molecules — is reshaping what comes next.
New research in young adults links long-term obesity to measurable biological aging — and points to metabolism as the load-bearing pillar of longevity.